# Paradigm Uses OpenAI Technology to Connect Patients with Clinical Trials

OpenAI announced that healthcare company Paradigm is leveraging OpenAI's API to improve how patients find and access clinical trials.

Clinical trials are essential for developing new treatments, but matching patients with appropriate studies has traditionally been a complex, time-consuming process. Patients often struggle to find trials they qualify for, while researchers face challenges recruiting suitable participants.

Paradigm's AI-powered solution addresses this gap by using OpenAI's technology to streamline the matching process. The system can quickly analyze patient information and trial requirements to identify relevant opportunities, potentially connecting more patients with studies that could benefit them.

This application demonstrates how AI is moving beyond consumer applications into critical healthcare infrastructure. Better trial access means patients gain earlier access to innovative treatments, while researchers can recruit participants more efficiently—ultimately accelerating medical research.

The announcement from OpenAI highlights a growing trend of AI companies